Demetra Philippidou

Belvaux, ES L4367, Luxembourg

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma.

High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 27, 2025

A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma.

A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma.

Journal: Cancer gene therapy

Published: March 24, 2023

Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response.

Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response.

Journal: Cell reports

Published: November 30, 2022

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.

Journal: Cell death & disease

Published: October 03, 2022

Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells.

Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells.

Journal: Cancers

Published: January 26, 2021

Systematic Transcriptional Profiling of Responses to STAT1- and STAT3-Activating Cytokines in Different Cancer Types.

Systematic Transcriptional Profiling of Responses to STAT1- and STAT3-Activating Cytokines in Different Cancer Types.

Journal: Journal of molecular biology

Published: July 20, 2020

Hypoxia-Induced Adaptations of miRNomes and Proteomes in Melanoma Cells and Their Secreted Extracellular Vesicles.

Hypoxia-Induced Adaptations of miRNomes and Proteomes in Melanoma Cells and Their Secreted Extracellular Vesicles.

Journal: Cancers

Published: February 27, 2020

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells.

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 29, 2018

A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells.

A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells.

Journal: Molecular cancer

Published: May 14, 2018

Impact of BRAF kinase inhibitors on the miRNomes and transcriptomes of melanoma cells.

Impact of BRAF kinase inhibitors on the miRNomes and transcriptomes of melanoma cells.

Journal: Biochimica et biophysica acta. General subjects

Published: December 14, 2016

Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?

Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?

Journal: Oncotarget

Published: January 21, 2015

New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.

New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.

Journal: PloS one

Published: March 28, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026